These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 23112217)

  • 1. Predictors of outcome in routine care for Cryptococcal meningitis in Western Kenya: lessons for HIV outpatient care in resource-limited settings.
    Kendi C; Penner J; Koech J; Nyonda M; Cohen CR; Bukusi EA; Ngugi E; Meyer AC
    Postgrad Med J; 2013 Feb; 89(1048):73-7. PubMed ID: 23112217
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The impact of routine cryptococcal antigen screening on survival among HIV-infected individuals with advanced immunosuppression in Kenya.
    Meyer AC; Kendi CK; Penner JA; Odhiambo N; Otieno B; Omondi E; Opiyo E; Bukusi EA; Cohen CR
    Trop Med Int Health; 2013 Apr; 18(4):495-503. PubMed ID: 23368667
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A retrospective study of AIDS-associated cryptomeningitis.
    Sachdeva RK; Randev S; Sharma A; Wanchu A; Chakrabarti A; Singh S; Varma S
    AIDS Res Hum Retroviruses; 2012 Oct; 28(10):1220-6. PubMed ID: 22369456
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Laboratory-Reflex Cryptococcal Antigen Screening Is Associated With a Survival Benefit in Tanzania.
    Faini D; Kalinjuma AV; Katende A; Mbwaji G; Mnzava D; Nyuri A; Glass TR; Furrer H; Hatz C; Boulware DR; Letang E
    J Acquir Immune Defic Syndr; 2019 Feb; 80(2):205-213. PubMed ID: 30422904
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term follow-up and survival of antiretroviral-naive patients with cryptococcal meningitis in the pre-antiretroviral therapy era, Gauteng Province, South Africa.
    Park BJ; Shetty S; Ahlquist A; Greenbaum A; Miller JL; Motsi A; McCarthy K; Govender N;
    Int J STD AIDS; 2011 Apr; 22(4):199-203. PubMed ID: 21515751
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cryptococcal antigenemia is associated with meningitis or death in HIV-infected adults with CD4 100-200 cells/mm
    Wykowski J; Galagan SR; Govere S; Wallis CL; Moosa MY; Celum C; Drain PK
    BMC Infect Dis; 2020 Jan; 20(1):61. PubMed ID: 31959112
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic markers in AIDS-related cryptococcal meningitis.
    Majumder S; Mandal SK; Bandyopadhyay D
    J Assoc Physicians India; 2011 Mar; 59():152-4. PubMed ID: 21751623
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MORTALITY AFTER CLINICAL MANAGEMENT OF AIDS-ASSOCIATED CRYPTOCOCCAL MENINGITIS IN KENYA.
    Baldassarre R; Mdodo R; Omonge E; Jaoko W; Baddley J; Pappas P; Aban I; Odera S; Suleh A; Jolly PE
    East Afr Med J; 2014 May; 91(5):145-51. PubMed ID: 25684784
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ending deaths from HIV-related cryptococcal meningitis by 2030.
    Shroufi A; Chiller T; Jordan A; Denning DW; Harrison TS; Govender NP; Loyse A; Baptiste S; Rajasingham R; Boulware DR; Ribeiro I; Jarvis JN; Van Cutsem G
    Lancet Infect Dis; 2021 Jan; 21(1):16-18. PubMed ID: 33271065
    [No Abstract]   [Full Text] [Related]  

  • 10. Cryptococcal meningitis in HIV-infected patients: a longitudinal study in Cambodia.
    Espié E; Pinoges L; Balkan S; Chanchhaya N; Molfino L; Narom P; Pujades-Rodríguez M
    Trop Med Int Health; 2010 Nov; 15(11):1375-81. PubMed ID: 20868415
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical presentation, natural history, and cumulative death rates of 230 adults with primary cryptococcal meningitis in Zambian AIDS patients treated under local conditions.
    Mwaba P; Mwansa J; Chintu C; Pobee J; Scarborough M; Portsmouth S; Zumla A
    Postgrad Med J; 2001 Dec; 77(914):769-73. PubMed ID: 11723315
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence of Asymptomatic Cryptococcal Antigenemia and Association with Follow-up Risk of Cryptococcal Meningitis and Mortality among HIV Infected Patients in North West India: A Prospective Cohort Study.
    Bhati R; Pramendra S; Sejoo B; Kumar D; Bohra GK; Meena DS; Verma D; Midha NK
    Curr HIV Res; 2021; 19(1):35-39. PubMed ID: 32860359
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A pragmatic approach to managing antiretroviral therapy-experienced patients diagnosed with HIV-associated cryptococcal meningitis: impact of antiretroviral therapy adherence and duration.
    Alufandika M; Lawrence DS; Boyer-Chammard T; Kanyama C; Ndhlovu CE; Mosepele M; Tugume L; Meya D; Boulware DR; Rhein J; Muzoora C; Youssouf N; Molloy SF; Schutz C; Lortholary O; Meintjes G; Mwandumba HC; Harrison TS; Jarvis JN;
    AIDS; 2020 Jul; 34(9):1425-1428. PubMed ID: 32590438
    [No Abstract]   [Full Text] [Related]  

  • 14. Early versus delayed initiation of antiretroviral therapy for concurrent HIV infection and cryptococcal meningitis in sub-saharan Africa.
    Makadzange AT; Ndhlovu CE; Takarinda K; Reid M; Kurangwa M; Gona P; Hakim JG
    Clin Infect Dis; 2010 Jun; 50(11):1532-8. PubMed ID: 20415574
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Different presentations and outcomes between HIV-infected and HIV-uninfected patients with Cryptococcal meningitis.
    Liao CH; Chi CY; Wang YJ; Tseng SW; Chou CH; Ho CM; Lin PC; Ho MW; Wang JH
    J Microbiol Immunol Infect; 2012 Aug; 45(4):296-304. PubMed ID: 22608531
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of a national cryptococcal antigen screening program for HIV-infected patients in Uganda: A cost-effectiveness modeling analysis.
    Rajasingham R; Meya DB; Greene GS; Jordan A; Nakawuka M; Chiller TM; Boulware DR; Larson BA
    PLoS One; 2019; 14(1):e0210105. PubMed ID: 30629619
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Asymptomatic cryptococcal antigenemia is associated with mortality among HIV-positive patients in Indonesia.
    Ganiem AR; Indrati AR; Wisaksana R; Meijerink H; van der Ven A; Alisjahbana B; van Crevel R
    J Int AIDS Soc; 2014; 17(1):18821. PubMed ID: 24476751
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuroimaging of HIV-associated cryptococcal meningitis: comparison of magnetic resonance imaging findings in patients with and without immune reconstitution.
    Katchanov J; Branding G; Jefferys L; Arastéh K; Stocker H; Siebert E
    Int J STD AIDS; 2016 Feb; 27(2):110-7. PubMed ID: 25693580
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of acute cryptococcal meningitis in HIV infected adults, with an emphasis on resource-limited settings.
    Sloan D; Dlamini S; Paul N; Dedicoat M
    Cochrane Database Syst Rev; 2008 Oct; (4):CD005647. PubMed ID: 18843697
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mortality from HIV-associated meningitis in sub-Saharan Africa: a systematic review and meta-analysis.
    Tenforde MW; Gertz AM; Lawrence DS; Wills NK; Guthrie BL; Farquhar C; Jarvis JN
    J Int AIDS Soc; 2020 Jan; 23(1):e25416. PubMed ID: 31957332
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.